Federal contract award

W81K0225FA138

DIASORIN LIAISON MDX SUPPLY KITS DO

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeW40M MRCO PACIFIC
NAICS325413 — In-Vitro Diagnostic Substance Manufacturing
PSC6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
Parent award / vehicleW81K0225DA018
Set-asideNot reported
Pricing typeFIRM FIXED PRICE
Obligations$0
Current contract value$61.6K
Potential contract value / ceiling$61.6K
Start dateOct 1, 2025
Current end dateSep 30, 2026
Potential end dateSep 30, 2026
Latest award activityFeb 19, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Feb 19, 2026P00003$-61.6KMOD IS TO TERMINATE THIS DO AT NO COST. CONTRACT WAS AWARDED TO THE WRONG NAME AND CAGE. IT SHOULD HAVE BEEN AWARDED TO DIASORIN MOLECULAR INC (CAGE: 7V7H8). NEW DO WILL BE ISSUED WITH THE CORRECT VENDOR NAME USING THE SAME TERMS AND CONDITIONS.
Jan 7, 2026P00002$61.6KTHE PURPOSE OF THIS MODIFICATION IS TO ADD FY26 FUNDING IN THE AMOUNT OF $61,602.00 WHICH ARE PRESENTLY AVAILABLE AND ALLOTTED FOR 01 OCTOBER 2025 - 30 SEPTEMBER 2026.
Jan 6, 2026P00001$0DIASORIN LIAISON MDX SUPPLY KITS DO
Sep 18, 20250$0DIASORIN LIAISON MDX SUPPLY KITS DO

Research next steps

  1. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.